IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
490,30 € ↑19,90 (4,23%)
2026-06-04
DEL PRIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership1,226 shares
Latest Disclosed Value $ 688,877
Pinnacle Associates Ltd reports 0.08% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 1,226 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $598,288 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,227 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -0.08% during the quarter. The current value of the position is $601,108 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F IDEXX LABS COM 45168D104 1,226 -1 -0.08 689 -17.11 0.0088
2026-02-05 2025-12-31 13F IDEXX LABS COM 45168D104 1,227 18 1.49 830 7.51 0.0107
2025-11-13 2025-09-30 13F IDEXX LABS COM 45168D104 1,209 28 2.37 772 21.96 0.0102
2025-08-04 2025-06-30 13F IDEXX LABS COM 45168D104 1,181 -330 -21.84 633 -0.16 0.0092
2025-05-06 2025-03-31 13F IDEXX LABS COM 45168D104 1,511 -180 -10.64 635 -9.30 0.0093
2025-02-14 2024-12-31 13F IDEXX LABS COM 45168D104 1,691 -379 -18.31 699 -39.11 0.0095
2024-10-25 2024-09-30 13F IDEXX LABS COM 45168D104 2,070 171 9.00 1,149 24.11 0.0195
2024-07-30 2024-06-30 13F IDEXX LABS COM 45168D104 1,899 11 0.58 925 -9.22 0.0145
2024-04-26 2024-03-31 13F IDEXX LABS COM 45168D104 1,888 -182 -8.79 1,019 -11.24 0.0161
2024-01-19 2023-12-31 13F IDEXX LABS COM 45168D104 2,070 -18 -0.86 1,149 25.74 0.0193
2023-10-24 2023-09-30 13F IDEXX LABS COM 45168D104 2,088 12 0.58 913 -12.38 0.0170
2023-07-27 2023-06-30 13F IDEXX LABS COM 45168D104 2,076 2,076 1,043 0.0181
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.